Search Results
Search results for "Addex Therapeutics"
Results found for "Addex Therapeutics"
- Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem
He argues for a therapeutic strategy built around modulators that can be combined, rather than single His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics
- Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires | Dr. GPCR Ecosystem
modulate drug seeking, habit formation, and reward processing - and has been pursued as a potential therapeutic adolescent alcohol exposure disrupts mGlu2 function in the striatum in a way that might seem to close off therapeutic
- FAQ | Dr. GPCR Ecosystem
Each session explores mechanistic models, translational challenges, and real-world therapeutic implications
- Qing Fan: Inside the Architecture of Class C GPCRs | Dr. GPCR Ecosystem
mutations in the GABA-B transmembrane domain and what they suggest about precision pharmacology The therapeutic But its therapeutic window is narrow.
- Eurofins Discovery GPCR Solutions | Drug Discovery & Development Partner | Dr. GPCR
profiling, selectivity, and promiscuity gpcrMAX orphanMAX Chemokine obesityLITE Peptide Hormone Class B Therapeutic
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
By integrating advanced tools and translational biology, his work directly informs therapeutic strategies
- Our History | Dr. GPCR Ecosystem
Sep 20, 2022 — First contributor article published: Therapeutic validation of an orphan G protein‐coupled
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
analysis, revealed nuanced roles of RGS4, RGS9, and RGSZ — not just as modulators but as potential therapeutic
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
Clements' work is primarily focused on translational developments of small molecule therapeutics, and
- GPCR Webinars | Dr. GPCR Ecosystem
Each session explores mechanistic models, translational challenges, and real-world therapeutic implications
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
structural biology and drug discovery, where molecular structures inform the design and development of new therapeutics You could easily imagine separate therapeutic programs targeting those different physiological effects
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
This could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
The canonical assumption that targeting PLC would be therapeutic has failed in the clinic, and patients
- Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics
- Randy Hall: Adhesion GPCRs and the Tail Nobody Wanted | Dr. GPCR Ecosystem
model his lab proposed in 2011, and why a family once dismissed as undruggable now looks like a serious therapeutic
- Foord: Serendipity, RAMPs, And Industrial GPCR Pharmacology | Dr. GPCR Ecosystem
Later hepatotoxicity concerns and the success of antibody therapeutics further shifted strategy.
- Yamina Berchiche: Beyond the Lab — From Chemokine Receptors to the Dr. GPCR Ecosystem | Dr. GPCR Ecosystem
has reached only about 166 of them, leaving more than 250 receptors unstudied at anything close to therapeutic
- Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem
to produce a distinct complex - different ligand selectivity, different signaling profile, different therapeutic
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
symptomatic of a deeper challenge: the field has not yet fully characterized which signaling pathways produce therapeutic
- Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem
of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
activation, and resistant to pharmacological blockade - and why those properties have shaped both the therapeutic
- Lin and Ball: GPCR Antibody Characterization and the Recombinant Shift | Dr. GPCR Ecosystem
research 36:55 If not antibodies - Ball and Lin on the power of scientific communication 39:40 The GPCR therapeutic
- Revvity | Dr. GPCR Ecosystem
Whether you’re decoding signaling pathways or designing the next generation of therapeutics, Revvity
- Fresh, Fresh, GPCR News ❇ Feb 17 - 23, 2025 | Dr. GPCR Ecosystem
Terry Kenakin’s unique course, Development of GPCR Ligands as Therapeutic Drugs , and gain essential signaling and drug discovery Symposium & Workshop - Brazil NEW April 1 - 3, 2025 | 2nd Peptide-Based Therapeutics Summit - USA April 2 - 3, 2025 | New therapeutic modalities: Transforming receptor pharmacology - UK Australia GPCR Jobs NEW Open Postdoctoral position - Stanford University Structural Biologist - Confo Therapeutics Pharmacologist - Schrödinger Scientist - Biology - Superluminal Medicines Scientist I Cell Biology - Tectonic Therapeutic
- Your GPCR Order Has Arrived! ❇ Feb 10 - 16, 2025 | Dr. GPCR Ecosystem
. 🗓️ Upcoming 4-Week Course: Development of GPCR Ligands as Therapeutic Drugs starting March 20 – April biotechs public Aikium's AI-Driven mRNA Engine Looks to Address Undruggable Disordered Proteins Tectonic Therapeutic - 21, 2025 | 2nd GPCR signaling and drug discovery Symposium & Workshop NEW April 2 - 3, 2025 | New therapeutic PhD Position GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic
- Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem
visualization to become quantitative tools for understanding receptor activation and guiding GPCR-targeted therapeutics
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
. 💊 Therapeutic Potential : Understanding bias enables researchers to design drugs that target specific Kenakin challenges the traditional approach and encourages leveraging bias for better therapeutic outcomes
























